Gonorrhea is a sexually transmitted disease (STD) caused by N. gonorrhea, which can infect the genital tract, rectum, or pharynx. One complication of this STD is the spread of the bacterial pathogen to the blood and other sites. This is known as gonococcemia, which is also referred to as disseminated gonococcal infection. Disseminated disease affects up to 3% of individuals with gonorrhea [1] and develops within 2 to 3 weeks after a primary genital infection [2].

The clinical picture of gonococcemia will typically feature a rash, polyarthralgia, and tenosynovitis [3], although not all three have to be present for the diagnosis. Cutaneous manifestations are described below. The arthralgia encompasses numerous, asymmetrical joints and is typically associated with sterile culture from synovial fluid [4] [5]. Polyarthralgia and tenosynovitis more commonly involve the joints of the hands and feet such as wrists and ankles [6].

The risk factors for gonococcemia include the female gender, multiple sexual partners, pregnancy, menses, low socioeconomic status, intravenous drug use, HIV, hypocomplementemia, and systemic lupus erythematosus [7].

Complications

Meningitis [4], myocarditis [8], and hepatic abscess formation [9] are among the rare sequelae of gonococcemia.

Physical exam

The patient's vital signs are notable for a low-grade fever. With regards to the rash, the skin lesions are characterized as vesicular, maculopapular, pustular or vesicular and they appear on the limbs, palms, soles, and trunk [4]. Remarkable findings on the musculoskeletal exam include tenderness and erythema of the involved joints and tendon sheaths as well as limited range of motion.

Patients with gonococcal meningitis exhibit meningeal signs and mental status changes while those with gonococcal endocarditis develop tachycardia and a new murmur.

As a frequent cause of medical visits in young sexually active adults [10], gonococcemia should be suspected when an individual in this population presents with at least a rash and tenosynovitis [3]. Moreover, it is paramount to diagnose and treat these patients promptly to prevent complications. The workup is composed of the patient's history and risk factors, physical exam, and the appropriate studies.

Laboratory tests

The microbial diagnostic tools include culture and/or nucleic acid amplification tests (NAATs) of samples obtained from the genital tract, extragenital sites, blood, synovial fluid, skin, and cerebrospinal fluid if applicable [5] [11]. Also, blood and joint fluid specimens should be assessed with a Gram stain.

With regards to the results, negative findings do not rule out the diagnosis of gonococcemia. For example, joint aspirates, skin lesions, and blood cultures are commonly sterile in these patients [3] [6] while asymptomatic sites may demonstrate an infection [3].

Further important studies include a complete blood count (CBC), which may reveal mild leukocytosis, and erythrocyte sedimentation rate (ESR), which can be slightly elevated.

Other

The United States Preventive Services Task Force (USPSTF) recommends screening for the presence of concurrent STDs such as chlamydia, syphilis, and HIV [12]. Additionally, women of reproductive age with STDs should have a pregnancy test.

Procedures

Patients with affected joints should undergo fluid aspiration and those suspected to have meningitis warrant a lumbar puncture.

The primary treatment for gonococcemia is antibiotics. The Centers for Disease Control and Prevention (CDC) recommends a combination of intravenous ceftriaxone and oral azithromycin. This regimen is effective in eradicating the infection. In cases of joint involvement, drainage of the affected joint may be necessary. It is crucial to treat sexual partners to prevent reinfection and further spread of the disease.

With prompt and appropriate treatment, the prognosis for gonococcemia is generally good. Most patients respond well to antibiotics and recover without long-term complications. However, if left untreated, the infection can lead to serious complications, including chronic joint damage and, in rare cases, life-threatening conditions such as endocarditis or meningitis.

Gonococcemia is caused by the bacterium Neisseria gonorrhoeae. This organism is transmitted through sexual contact and can infect the mucous membranes of the genitals, rectum, and throat. In some individuals, the bacteria can invade the bloodstream, leading to disseminated infection. Factors that may increase the risk of dissemination include a weakened immune system and certain strains of the bacteria that are more virulent.

Gonococcemia is relatively rare compared to localized gonorrhea infections. It is more common in women than men and often occurs in individuals aged 15-29 years. The incidence of gonococcemia has decreased with the advent of effective antibiotic treatments for gonorrhea. However, the emergence of antibiotic-resistant strains of Neisseria gonorrhoeae poses a potential threat to controlling the spread of this infection.

The pathophysiology of gonococcemia involves the spread of Neisseria gonorrhoeae from the initial site of infection to the bloodstream. Once in the bloodstream, the bacteria can disseminate to various parts of the body, including the skin and joints. The immune response to the infection can lead to inflammation and the characteristic symptoms of fever, skin lesions, and joint pain.

Preventing gonococcemia involves reducing the risk of gonorrhea infection. This can be achieved through safe sexual practices, including the use of condoms and regular screening for sexually transmitted infections. Prompt treatment of gonorrhea infections can prevent the bacteria from spreading to the bloodstream. Educating individuals about the risks and symptoms of gonorrhea and gonococcemia is also crucial in prevention efforts.

Gonococcemia is a systemic infection caused by the spread of Neisseria gonorrhoeae through the bloodstream. It presents with symptoms such as fever, skin lesions, and joint pain. Diagnosis involves clinical evaluation and laboratory tests, and treatment consists of antibiotics. With timely intervention, the prognosis is generally favorable. Preventive measures focus on reducing the risk of gonorrhea infection and its complications.

If you suspect you have symptoms of gonococcemia, it is important to seek medical evaluation. Symptoms may include fever, skin rashes, and joint pain. Early diagnosis and treatment with antibiotics are crucial for a good outcome. Practicing safe sex and getting regular screenings for sexually transmitted infections can help prevent gonococcemia. If you have been diagnosed with gonorrhea, ensure that your sexual partners are also treated to prevent reinfection and further spread of the disease.

1. Hook EW III, Handsfield HH. Gonococcal infections in the adult. In: Holmes KK, Sparling PF, Stamm WE, et al., eds. Sexually Transmitted Diseases. 4th ed. New York, NY: McGraw-Hill; 2008.
2. Brown TJ, Yen-Moore A, Tyring SK. An overview of sexually transmitted diseases. Part I. J Am Acad Dermatol. 1999;41(4):511–532.
3. Lohani S, Nazir S, Tachamo N, Patel N. Disseminated gonococcal infection: an unusual presentation. J Community Hosp Intern Med Perspect. 2016;6(3):31841.
4. Ross JD. Systemic gonococcal infection. Genitourin Med. 1996;72(6):404–7.
5. Rice PA. Gonococcal arthritis (disseminated gonococcal infection). Infect Dis Clin North Am. 2005;19(4):853–61.
6. Mayor MT, Roett MA, Uduhiri KA. Diagnosis and Management of Gonococcal Infections. Am Fam Physician. 2012;86(10):931-938.
7. Bardin T. Gonococcal arthritis. Best Pract Res Clin Rheumatol. 2003; 17(2):201-8.
8. Bunker D, Kerr LD. Acute myopericarditis likely secondary to disseminated gonococcal infection. Case Rep Infect Dis. 2015;2015:385126.
9. Lee MH, Byun J, Jung M, et al. Disseminated gonococcal infection presenting as bacteremia and liver abscesses in a healthy adult. Infect Chemother. 2015;47(1):60–3.
10. O'brien JP, Goldenberg DL, Rice PA. Disseminated gonococcal infection: A prospective analysis of 49 patients and a review of pathophysiology and immune mechanisms. Medicine (Baltimore) 1983;62(6):395–406.
11. Centers for Disease Control and Prevention (CDC). 2015 STD Treatment Guidelines. http://www.cdc.gov/std/tg2015/gonorrhea.htm. Accessed online December 8, 2016.
12. Meyers D, Wolff T, Gregory K, et al. USPSTF recommendations for STI screening. Am Fam Physician. 2008;77(6):819-24.